Cargando…
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers
Male breast cancer (MBC) is a rare disease. Due to its rarity, MBC research and clinical approach are mostly based upon data derived from female breast cancer (FBC). Increasing evidence indicate that on molecular level MBC may be an heterogeneous disease different from FBC. In order to investigate w...
Autores principales: | Rizzolo, Piera, Silvestri, Valentina, Valentini, Virginia, Zelli, Veronica, Zanna, Ines, Masala, Giovanna, Bianchi, Simonetta, Palli, Domenico, Ottini, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929425/ https://www.ncbi.nlm.nih.gov/pubmed/29731982 http://dx.doi.org/10.18632/oncotarget.24856 |
Ejemplares similares
-
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers
por: Rizzolo, Piera, et al.
Publicado: (2016) -
Mutation screening of RAD51C in male breast cancer patients
por: Silvestri, Valentina, et al.
Publicado: (2011) -
SULT1A1 gene deletion in BRCA2-associated male breast cancer: a link between genes and environmental exposures?
por: Palli, Domenico, et al.
Publicado: (2013) -
Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance
por: Zelli, Veronica, et al.
Publicado: (2021) -
Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy
por: Palli, Domenico, et al.
Publicado: (2007)